Insight

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Insight

New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo – LUNGevity Foundation

Photo from Jarushka Naidoo/X

Apr 11, 2024, 13:50

New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo – LUNGevity Foundation

LUNGevity Foundation shared on X/Twitter:

“50% patients develop side effects from immunotx. New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity and require proactive monitoring. Important question esp for PD-L1>50% Great presentation by Jarushka Naidoo. AACR24″

Source: LUNGevity Foundation/X

AACR24 blood test cancer Jarushka Naidoo LUNGevity Foundation OncoDaily Oncology proactive monitoring toxicity

Oct 9, 2024, 09:37

Rick Buck: Vivek Subbiah on Leveraging Social Media for Professional Growth and Networking

Oct 9, 2024, 09:34

Nelson Dusetti: The importance of molecular signatures in the personalization of treatments for PDAC

Oct 9, 2024, 09:33

Jennifer Wargo's Keynote Lecture on the Microbiome ENA Symposium 2024 - EORTC

Oct 9, 2024, 09:31

Fumiko Ladd Chino: Inpatient care among cancer patients based on housing status

Oct 9, 2024, 09:27

Margaret Foti: AACR has awarded more than 1,000 grants for cancer research since 1993

Oct 9, 2024, 09:25

Aaron Goodman: New Acute Leukemia case in the ICU

Oct 9, 2024, 09:22

ASCO24 Updates: Dr. Isabel Preeshagul on Optimizing Clinical Trials and Overcoming Barriers

Oct 9, 2024, 08:29

Neil Ranasinghe: My last video for Childhood Cancer Awareness Month

Oct 9, 2024, 08:26

Maryam Lustberg: Survivorship oncology care for advanced or metastatic cancer - MASCC-ASCO recommendations

Oct 9, 2024, 08:23

Robin Zon: The many benefits of being an ASCO member

Oct 9, 2024, 08:16

Meet Simon Patton at ISLB24 - International Society of Liquid Biopsy

Oct 9, 2024, 08:13

UICC and WHO highlight meaningful engagement of Cancer Survivors and Patients in Global Health Policies